BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8197967)

  • 1. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
    Uusimaa P; Ruskoaho H; Vuolteenaho O; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
    Int J Cardiol; 1999 Apr; 69(1):5-14. PubMed ID: 10362366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of Nt-proANP and C-ANP.
    McDowell G; Patterson C; Maguire S; Shaw C; Nicholls DP; Hall C
    Eur J Clin Invest; 2002 Aug; 32(8):545-8. PubMed ID: 12190952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
    Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
    Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
    Arjamaa O; Karlqvist K; Vainionpää V; Leppäluoto J; Vuolteenaho O
    Acta Physiol Scand; 1996 Aug; 157(4):481-5. PubMed ID: 8869731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
    Brueckmann M; Bertsch T; Hoffmann U; Lang S; Kaden JJ; Wolpert C; Huhle G; Borggrefe M; Haase KK
    Clin Chem Lab Med; 2004; 42(8):896-902. PubMed ID: 15387439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.
    Phillips PA; Sasadeus J; Hodsman GP; Horowitz J; Saltups A; Johnston CI
    Br Heart J; 1989 Feb; 61(2):139-43. PubMed ID: 2522310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty.
    Klinge R; Jørgensen B; Thaulow E; Sirnes PA; Hall C
    Int J Cardiol; 1999 Jan; 68(1):1-8. PubMed ID: 10077394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure.
    Azizi C; Maistre G; Kalotka H; Isnard R; Barthélemy C; Masson F; Pham P; Pousset F; Eurin J; Lechat P; Komajda M; Carayon A
    J Endocrinol; 1996 Jan; 148(1):51-7. PubMed ID: 8568471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.